NCT00252291View on ClinicalTrials.gov

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

September 30, 2006

Conditions
Asthma
Interventions
DRUG

Aridol

DRUG

Methacholine

PROCEDURE

Exercise challenge

Trial Locations (1)

80230-6405

Colorado Asthma and Allergy Centers, 125 Rampart Way, Denver

Sponsors

Lead Sponsor

Syntara
All Listed Sponsors
lead

Syntara

INDUSTRY

NCT00252291 - Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics | Biotech Hunter | Biotech Hunter